" /> WT1 gene exon 1 2 transcript/control transcript:NRto:Pt:Bld/Tiss:Qn:Molgen - CISMeF





Preferred Label : WT1 gene exon 1 2 transcript/control transcript:NRto:Pt:Bld/Tiss:Qn:Molgen;

LOINC status : ACTIVE;

LOINC display name : WT1 gene exon 1 2 transcript/control transcript Molgen (Bld/Tiss) [# ratio];

LOINC long common name : WT1 gene exon 1 2 transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method;

LOINC short name : WT1 ex 1 2/control Bld/T;

LOINC description : Wilm's tumor (WT1) gene expression is calculated by measuring the copy numbers of transcripts within exon 1 and 2 of the WTI gene compared to transcripts from a control gene. The WT1 gene expression is used as a specific molecular marker to improve diagnosis, prognosis and follow-up of adult acute myeloid leukemia (AML) patients. Early decreased expression of WT1 copy number in peripheral blood predicts better outcome for AML patients [PMID:20107153]. This code is based on, but not limited in use to, the submitter's package insert, Ipsogen's ProfileQuant kit. This kit uses real-time quantitative PCR to quantify WT1 gene expression relative to ABL1 control gene.;

Details


You can consult :


Nous contacter.
27/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.